Picture of Taisho Pharmaceutical Holdings Co logo

4581 — Taisho Pharmaceutical Holdings Co News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareBalancedLarge CapHigh Flyer

Table: Taisho Pharmaceutical HD -2018/19 parent results

May 13 (Reuters)- 
          Taisho Pharmaceutical Holdings Co Ltd 
          PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                   Year ended      Year ended       Year to     NEXT     
                Mar 31, 2019    Mar 31, 2018   Mar 31, 2020     YEAR     
                   LATEST         YEAR-AGO        COMPANY      COMPANY   
                   RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Revenues          15.62           7.24                                 
                (+115.7 pct)     (+1.5 pct)                              
  Operating         13.68           5.68                                 
                (+141.1 pct)     (+3.8 pct)                              
  Recurring         13.63           5.61                                 
                (+143.0 pct)     (+3.7 pct)                              
  Net               30.28           5.53                                 
                (+447.2 pct)     (-19.3 pct)                             
  EPS            379.01 yen       69.20 yen                              
  EPS Diluted    378.66 yen       69.15 yen                              
  Ann Div        120.00 yen      110.00 yen     110.00 yen               
  -Q2 Div         50.00 yen       50.00 yen      50.00 yen               
  -Q4 Div         70.00 yen       60.00 yen      60.00 yen               
  
  NOTE - Taisho Pharmaceutical Holdings Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4581.T

Recent news on Taisho Pharmaceutical Holdings Co

See all news